Alcohol and toxicity Journal of Hepatology

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Vitamin D for your patients with chronic hepatitis C?
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Leigh A. Beamish, Alvaro R. Osornio-Vargas, Eytan Wine 
The average rate at which alcohol is eliminated from the body is ∼7 g/h, which translates to ∼1 drink/h. Alcohol undergoes first pass gastric metabolism.
Immunotherapy of hepatocellular carcinoma
Hepatic CD141+IFNλ+ DC subset: One against all?
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications  Sven M. Francque, Denise van der Graaff, Wilhelmus.
Obesity and Cancer: The Oil that Feeds the Flame
PNPLA3 gene in liver diseases
Pathological roles of purinergic signaling in the liver
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
Pathways of liver injury in alcoholic liver disease
The inflammasome in liver disease
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
T. Vescovo, G. Refolo, G. Vitagliano, G.M. Fimia, M. Piacentini 
Gianluca Tell, Carlo Vascotto, Claudio Tiribelli  Journal of Hepatology 
The role of air pollutants in atopic dermatitis
Volume 120, Issue 6, Pages (May 2001)
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Grand Rounds: Alcoholic Hepatitis
Endoplasmic reticulum stress in liver disease
Living donor liver transplantation: is the hype over?
NAFLD: A multisystem disease
Volume 55, Issue 4, Pages (October 2011)
Mechanisms of HBV-related hepatocarcinogenesis
Volume 69, Issue 2, Pages (August 2018)
Volume 61, Issue 2, Pages (August 2014)
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
I. Carmona, P. Cordero, J. Ampuero, A. Rojas, M. Romero-Gómez 
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Trends in the management and burden of alcoholic liver disease
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Pathways of liver injury in alcoholic liver disease
Scheme of the immune system in HCC surveillance and the metabolic effects of alcohol exposure on hepatocyte. Scheme of the immune system in HCC surveillance.
Vitamin D for your patients with chronic hepatitis C?
The genetics of alcohol dependence and alcohol-related liver disease
S. Tamir Rashid, Graeme J.M. Alexander  Journal of Hepatology 
Cannabinoid signaling and liver therapeutics
Volume 146, Issue 4, Pages e1 (April 2014)
Volume 63, Issue 2, Pages (August 2015)
Senescence in chronic liver disease: Is the future in aging?
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
Volume 148, Issue 3, Pages (March 2015)
NASH animal models: Are we there yet?
Volume 61, Issue 1, Pages S79-S90 (November 2014)
miR-122 – A key factor and therapeutic target in liver disease
Immigration and viral hepatitis
Kornelius Schulze, Jean-Charles Nault, Augusto Villanueva 
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
Autophagy in liver diseases: Time for translation?
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Inflammatory pathways in alcoholic steatohepatitis
Volume 58, Issue 4, Pages (April 2013)
Nathalie Ganne-Carrié, Pierre Nahon  Journal of Hepatology 
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Presentation transcript:

Alcohol and toxicity Journal of Hepatology Ivan Rusyn, Ramon Bataller  Journal of Hepatology  Volume 59, Issue 2, Pages 387-388 (August 2013) DOI: 10.1016/j.jhep.2013.01.035 Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig Layered graph showing the mechanisms of alcohol-induced toxicity and organ damage. Layer #1: the amount of alcohol intake is a main determinant of toxicity. Layer #2: alcohol metabolism is regulated by several enzymes and is a major determinant of alcohol-induced toxicity. Genetic variations and expression of these enzymes regulate systemic and local effects of alcohol intake. Layer #3: alcohol metabolites and molecules released in damaged organs, such as acetaldehyde and ROS, are key toxicity mediators with powerful biological properties. Layer #4: such mediators activate several cellular and molecular mechanisms, such as disrupted lipid metabolism, hypoxia, ER stress, dysregulated immunity, changes in intestinal microbiota and DNA damage. Layer #5: the synergistic effect of the activation of these pathways leads to different histological disturbances in target tissues, such as fat accumulation, inflammation (PMN cells), necrosis/apoptosis, fibrosis and cancer, leading to organ dysfunction. Layer #6: the most susceptible organs to the deleterious effects of alcohol, that account for most of clinical complications, include normal development of the fetus, liver, kidney, nervous system, aero-digestive tract, reproductive system, pancreas, and cardiovascular system. Layer #7: the individual susceptibility to the toxic effects of alcohol in the human body is determined by genetic (gender, SNPs in target genes such as PNPLA3), dietary, and environmental exposures. Finally, patients with co-morbidities, such as viral infections or metabolic disorders, are more susceptible to the deleterious effects of alcohol abuse. EtOH, ethanol; ADH, alcohol dehydrogenase; ALDH, acetaldehyde dehydrogenase; ER, endoplasmic reticulum; PNPLA3, patatin-like phospholipase domain-containing protein 3; SNPs, single nucleotide polymorphism. Journal of Hepatology 2013 59, 387-388DOI: (10.1016/j.jhep.2013.01.035) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions